Keywords
Acquired Immunodeficiency Syndrome
HIV-associated nephropathy
Chronic Kidney Disease
End-Stage Renal Disease
Kidney Biopsy
Focal Segmental Glomerulosclerosis
Peru
How to Cite
Abstract
Background: HIV infection remains a problem in developing countries, and it is an infrequent cause of end-stage renal disease.
Purpose: to present an uncommon case of end-stage renal disease associated with HIV.
Case presentation: A 41-year-old mixed-race male from Cerro de Pasco at 4000 meters above sea level in the highlands of Peru, with a history of hypertension, developed anasarca, bipalpebral edema, and oliguria. During his progression, he presented with azotemia and clinical signs of renal disease, leading to the exclusion of secondary causes. A rapid test for the detection of HIV 1 and 2 antibodies returned reactive, prompting a renal biopsy. The findings included advanced glomerulosclerosis and tubulointerstitial nephritis associated with HIV. The patient began treatment with highly active antiretroviral therapy (HAART) and subsequently underwent peritoneal dialysis, showing improvement and a favorable prognosis.
Discussion and conclusion: This case is unusual as HIV-associated nephropathy is almost exclusively observed in black patients and it is currently rare to reach terminal stages. In this patient, nephrotic syndrome and renal failure were the first manifestations of HIV, highlighting the clinical relevance of these renal alterations in the context of the infection. Histopathological findings confirmed the diagnosis and underscore the importance of early detection and timely treatment to prevent progression to end-stage renal failure.
References
Wyatt CM, Klotman PE. HIV-1 and HIV-associated nephropathy 25 years later. Clin J Am Soc Nephrol. 2007;2(supl. 1):S20-4. https://doi.org/10.2215/cjn.03561006
Wyatt CM, Klotman PE, D'Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol. 2008;28(6):513-22. https://doi.org/10.1016/j.semnephrol.2008.08.005
Berro Rivera FB, Mapua Ansay MF, Golbin JM, Alfonso PGI, Mangubat GFE, Solita Menghrajani RH, et al. HIV-associated nephropathy in 2022. Glomerular Dis. 2022;3(1):1-11. https://doi.org/10.1159/000526868
Chen A, Yin L, Lee K, He JC. Similarities and differences between COVID-19-associated nephropathy and HIV-associated nephropathy. Kidney Dis. 2021;8(1):1-12. https://doi.org/10.1159/000520235
Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol. 2015;11(3):150-60. https://doi.org/10.1038/nrneph.2015.9
Diana NE, Naicker S. The changing landscape of HIV-associated kidney disease. Nat Rev Nephrol. 2024;20(5):330-46. https://doi.org/10.1038/s41581-023-00801-1
Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, et al. Documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH. Nefrología. 2014;34(supl. 2):1-81. http://doi.org/10.3265/Nefrologia.pre2014.Jul.12674
Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med. 1984;101(4):429-34. https://doi.org/10.7326/0003-4819-101-4-429
Organización Panamericana de la Salud (OPS). VIH/SIDA [internet]. Paho.org. [citado 2025 febr. 3]. https://www.paho.org/es/temas/vihsida
Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA, et al. HIV-associated nephropathy: links, risks and management. HIV AIDS. 2018;10:73-81. https://doi.org/10.2147/hiv.s141978
Arellan-Bravo L, Contreras Tovar AR, Zevallos Guerra VE, Vera-Gonzales GD, Hurtado-Alegre JL. Enfermedad renal crónica por glomeruloesclerosis focal y segmentaria asociada a VIH en adolescente. An Fac Med. 2024;85(3):315-9. https://doi.org/10.15381/anales.v85i3.27916
Kramer HJ, Stilp AM, Laurie CC, Reiner AP, Lash J, Daviglus ML, et al. African ancestry-specific alleles and kidney disease risk in Hispanics/Latinos. J Am Soc Nephrol. 2017;28(3):915-22. https://doi.org/10.1681/asn.2016030357
Perez-Gomez MV, Martin-Cleary C, Fernandez-Fernandez B, Ortiz A. Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development. Clin Kidney J. 2018;11(4):491-5. https://doi.org/10.1093/ckj/sfy070
Bonjoch A, Juega J, Echeverría P, Puig J, Perez-Alvarez N, Bonal J, et al. Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV. HIV Med. 2022;23(10):1078-84. https://doi.org/10.1111/hiv.13317
Ekrikpo UE, Kengne AP, Bello AK, Effa EE, Noubiap JJ, Salako BL, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443. https://doi.org/10.1371/journal.pone.0195443
Al-Suraimi A, Gelovani D, Rahman S, Soi V. HIV-associated nephropathy (HIVAN) in a patient with low viral load. Chest. 2023;164(4):A2674-5. https://doi.org/10.1016/j.chest.2023.07.1773
Naicker S, Rahmanian S, Kopp JB. HIV and chronic kidney disease. Clin Nephrol. 2015;83(7 supl. 1):32-8. https://doi.org/10.5414/cnp83s032
Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis. 2013;62(3):403-41. https://doi.org/10.1053/j.ajkd.2013.06.002
Lucas GM, Ross MJ, Stock PG, Shilpak MG, Wyatt CM, Gupta SK, et al. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(9):e96-138. https://doi.org/10.1093/cid/ciu617
Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, et al. Kidney Transplantation in HIV-Positive Patients: A Single-Center, 16-Year Experience. Am J Kidney Dis. 2019;73(1):112-8. https://doi.org/10.1053/j.ajkd.2018.02.352
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.